Total amount raised
$301 Million
Latest funding date
9/1/2024
Location
Viome has successfully raised significant funding through nine rounds, with the latest being a Series D round. The company is backed by 14 investors, including notable names like Marc Benioff and Khosla Ventures.
Viome's platform offers at-home microbiome tests that provide personalized health insights and recommendations, leveraging AI to analyze results and tailor supplements and dietary advice. Keep reading to explore the intricacies of Viome's fundraising journey and the investors backing this innovative platform.
What Is Viome?
Viome is a private company based in Bellevue, Washington, specializing in providing comprehensive health insights through microbiome testing. The company operates in the Dietary Supplements, Health Care, Medical, and Wellness industries and has an employee count between 101-250.
Viome leverages artificial intelligence to offer personalized health solutions aimed at uncovering the root causes of chronic diseases, cancer, and aging. The company has raised significant funding through a Series D round and is backed by 14 investors, including Marc Benioff and Khosla Ventures.
How Much Funding Has Viome Raised?
- Series A
- Amount Raised: USD 15,000,002
- Date: July 2017
- Lead Investors: Khosla Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop and launch Viome's initial microbiome testing products.
- Series B
- Amount Raised: USD 5,500,000
- Date: July 2018
- Lead Investors: Better Health Group
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand product offerings and enhance AI capabilities.
- Series B
- Amount Raised: USD 25,000,000
- Date: April 2019
- Lead Investors: Marc Benioff
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and enter new markets.
- Debt Financing
- Amount Raised: USD 3,000,000
- Date: February 2021
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support ongoing research and development.
- Series C
- Amount Raised: USD 54,000,000
- Date: November 2021
- Lead Investors: Ocgrow Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand diagnostic capabilities and product lines.
- Debt Financing
- Amount Raised: USD 20,000,000
- Date: January 2022
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund operational expenses and new initiatives.
- Series C
- Amount Raised: USD 67,004,494
- Date: October 2022
- Lead Investors: Bold Capital Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance AI-driven health solutions and expand market reach.
- Series C
- Amount Raised: USD 86,500,000
- Date: August 2023
- Lead Investors: Bold Capital Partners, Khosla Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the development of new diagnostic tests and expand retail sales.
- Series D
- Amount Raised: USD 25,000,000
- Date: September 2024
- Lead Investors: Khosla Ventures, Bold Capital WRG Ventures, Marc Benioff
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To launch a new diagnostic division and hire Kal Raman as COO.
Total Amount Raised: USD 296,004,496. Current Valuation: Not publicly disclosed.
Key Investors
- Marc Benioff
- Details: Marc Benioff is the founder, chairman, and CEO of Salesforce. He is known for his investments in technology and healthcare startups.
- Investment Focus Areas: Technology, healthcare, social impact
- Notable Investments: Salesforce, Twitter, Zoom
- Khosla Ventures
- Details: Khosla Ventures is a venture capital firm founded by Vinod Khosla, focusing on impactful technology investments.
- Investment Focus Areas: Technology, healthcare, sustainability, AI
- Notable Investments: Square, DoorDash, Impossible Foods
- Bold Capital
- Details: Bold Capital is a venture capital firm that invests in breakthrough technologies and transformative companies.
- Investment Focus Areas: Disruptive technologies, healthcare, life sciences
- Notable Investments: SpaceX, Virgin Hyperloop, Matternet
- WRG Ventures
- Details: WRG Ventures is a venture capital firm with a focus on innovative and high-growth potential companies.
- Investment Focus Areas: Early-stage technology, healthcare
- Notable Investments: Not specified
- Better Health Group
- Details: Better Health Group is an investment firm that focuses on healthcare and wellness sectors.
- Investment Focus Areas: Healthcare, wellness, medical technology
- Notable Investments: Not specified
What's Next for Viome?
Viome is poised to revolutionize the field of early disease detection and preventative health care. With the recent $25 million Series D funding, the company plans to expand its diagnostic offerings beyond the successful CancerDetect™ test to include tests for gut health conditions like IBS and IBD. The appointment of Kal Raman as COO, with his extensive experience at Amazon and Samsung, is expected to drive these initiatives forward.
The market for early disease detection is vast, given the low rates of preventive screenings in the U.S. Viome's innovative use of AI and RNA sequencing positions it well to capture a significant share of this market. Future fundraising opportunities are likely, as the company continues to demonstrate success and attract interest from high-profile investors like Khosla Ventures and Marc Benioff.
However, Viome will face challenges, including ensuring the accuracy and reliability of new diagnostic tests and navigating regulatory approvals. Competition in the personalized health and diagnostics market is fierce, but Viome's strategic vision and technological advancements provide a strong foundation for overcoming these hurdles.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Viome and gather other critical business insights. Sign up for free and start making data-driven decisions today.
